Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: 6-K, Date: 2018-01-03
Original SEC Filing: Click here

---

Webplus: CBPO/20180103/6-K/2_EX-99.1/000.htm SEC Original: tv482409_ex99-1.htm
FOR RELEASE January 3, 2018 China Biologic Announces Completion of Acquisition of TianXinFu from PWM Beijing, China—January 3, 2018— Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of China Biologic, commented, “We are pleased to welcome TianXinFu into the China Biologic family. We look forward to working with the team at TianXinFu to capitalize on the rapid growth of

---

---

Webplus: CBPO/20180103/6-K/3_EX-99.2/000.htm SEC Original: tv482409_ex99-2.htm
INVESTOR RIGHTS AGREEMENT Agreement THIS INVESTOR RIGHTS AGREEMENT (this “ (1) Company China Biologic Products Holdings, Inc., a Cayman Islands exempted company (the “ (2) Investor PW Medtech Group Limited, a Cayman Islands exempted company (the “ The parties listed above are referred to herein collectively as “Parties” and individually as a “Party.” RECITALS A. Share Exchange Agreement The Company

---

---

Webplus: CBPO/20180103/6-K/1/000.htm SEC Original: tv482409_6k.htm

---

Company Info:

Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: 6-K, Date: 2018-01-03CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125